Analysis
As the “Am Law Daily” blog noted last June, GlaxoSmithKline has an unusual strategy for dealing with the thousands of personal injury suits alleging that its controversial diabetes drug Avandia contributes to heart problems.
As the "Am Law Daily" blog noted last June, GlaxoSmithKline has an unusual strategy for dealing with the thousands of personal injury suits alleging that its controversial diabetes drug Avandia contributes to heart problems.
February 09, 2011 at 12:00 AM
1 minute read
The original version of this story was published on The Legal Intelligencer
Analysis
As the “Am Law Daily” blog noted last June, GlaxoSmithKline has an unusual strategy for dealing with the thousands of personal injury suits alleging that its controversial diabetes drug Avandia contributes to heart problems.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS